• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同一肺叶、多肺叶或混合性结节的肺癌患者死亡率增加:一项对来自监测、流行病学和最终结果(SEER)数据库的166,097名参与者的回顾性研究

Increased mortality in lung cancer patients with same-lobe, multi-lobe, or mixed nodules: a retrospective study of 166,097 participants from the SEER database.

作者信息

Ye Jiayue, Liu Jiacong, Ma Yucheng, Wang Yiqing, Xia Pinghui, Lv Wang, Hu Sheng, Hu Jian

机构信息

Department of Thoracic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Thoracic Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

J Thorac Dis. 2025 Jul 31;17(7):4439-4472. doi: 10.21037/jtd-2025-445. Epub 2025 Jul 28.

DOI:10.21037/jtd-2025-445
PMID:40809225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12340314/
Abstract

BACKGROUND

Lung cancer is a leading cause of cancer-related deaths globally, with a particularly high burden in China and a poor prognosis mainly due to late-stage diagnosis and limited effective treatments. Large-sample survival analyses are lacking for patients with lung cancer who nodules of present with same-lobe, multi-lobe, or mixed nodules, as well as those with multiple separate nodules. This study aimed to assess the survival rates of patients with lung cancer by focusing on overall survival and disease-specific survival.

METHODS

A large dataset of 166,097 patients with lung cancer was obtained from the Surveillance, Epidemiology, and End Results database. Survival analyses, including univariate, multivariate, and stratified analyses, and survival curves, were conducted using Empower Stats, SPSS 24, and GraphPad. Eight covariates, including age, sex, and race, were adjusted.

RESULTS

Compared to patients with a single-tumor, those with same-lobe nodules, multi-lobe nodules, or mixed-distribution nodules had a significantly increased mortality risk. Furthermore, stratified analysis indicated that, compared to patients with a single-tumor, the increase in mortality risk was substantially greater among patients who underwent surgical treatment than among those who did not receive surgery.

CONCLUSIONS

Patients with lung cancer who have satellite nodules located in the same-lobe or in different lobes on the same side as the primary tumor have a significantly higher mortality risk than those with single tumors. Surgical intervention in these patients further increases this risk.

摘要

背景

肺癌是全球癌症相关死亡的主要原因,在中国负担尤为沉重,且预后较差,主要是由于诊断较晚和有效治疗有限。对于出现同叶、多叶或混合结节以及多个独立结节的肺癌患者,缺乏大样本生存分析。本研究旨在通过关注总生存期和疾病特异性生存期来评估肺癌患者的生存率。

方法

从监测、流行病学和最终结果数据库中获取了一个包含166,097例肺癌患者的大型数据集。使用Empower Stats、SPSS 24和GraphPad进行生存分析,包括单变量、多变量和分层分析以及生存曲线分析。对年龄、性别和种族等八个协变量进行了调整。

结果

与单肿瘤患者相比,具有同叶结节、多叶结节或混合分布结节的患者死亡风险显著增加。此外,分层分析表明,与单肿瘤患者相比,接受手术治疗的患者死亡风险增加幅度明显大于未接受手术的患者。

结论

与单肿瘤患者相比,原发性肿瘤同侧同叶或不同叶有卫星结节的肺癌患者死亡风险显著更高。对这些患者进行手术干预会进一步增加这种风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/12340314/bd4a73b66144/jtd-17-07-4439-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/12340314/31ea7eaecb59/jtd-17-07-4439-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/12340314/bd4a73b66144/jtd-17-07-4439-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/12340314/31ea7eaecb59/jtd-17-07-4439-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54d5/12340314/bd4a73b66144/jtd-17-07-4439-f2.jpg

相似文献

1
Increased mortality in lung cancer patients with same-lobe, multi-lobe, or mixed nodules: a retrospective study of 166,097 participants from the SEER database.同一肺叶、多肺叶或混合性结节的肺癌患者死亡率增加:一项对来自监测、流行病学和最终结果(SEER)数据库的166,097名参与者的回顾性研究
J Thorac Dis. 2025 Jul 31;17(7):4439-4472. doi: 10.21037/jtd-2025-445. Epub 2025 Jul 28.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.未治疗的霍奇金淋巴瘤患者化疗和放疗在第二原发性恶性肿瘤、总生存期和无进展生存期方面的优化:个体参与者数据分析
Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.

本文引用的文献

1
Patient-reported outcomes in the early postoperative period following resection of unilateral multiple pulmonary nodules: implications for surgical decision-making.单侧多发肺结节切除术后早期患者报告的结局:对手术决策的影响
Transl Lung Cancer Res. 2025 Jan 24;14(1):27-39. doi: 10.21037/tlcr-24-702. Epub 2025 Jan 16.
2
Cancer incidence and mortality in China, 2022.2022年中国癌症发病率与死亡率
J Natl Cancer Cent. 2024 Feb 2;4(1):47-53. doi: 10.1016/j.jncc.2024.01.006. eCollection 2024 Mar.
3
The diagnosis and management of multiple ground-glass nodules in the lung.
肺部多发磨玻璃结节的诊断与处理。
Eur J Med Res. 2024 Jun 1;29(1):305. doi: 10.1186/s40001-024-01904-6.
4
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges.非小细胞肺癌中靶向治疗和免疫治疗的耐药机制:克服挑战的有前景策略
Front Immunol. 2024 Apr 9;15:1366260. doi: 10.3389/fimmu.2024.1366260. eCollection 2024.
5
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
6
How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology.如何使用监测、流行病学和最终结果(SEER)数据:研究设计和方法。
Mil Med Res. 2023 Oct 31;10(1):50. doi: 10.1186/s40779-023-00488-2.
7
Prognostic factors and survival prediction of resected non-small cell lung cancer with ipsilateral pulmonary metastases: a study based on the Surveillance, Epidemiology, and End Results (SEER) database.基于监测、流行病学和最终结果(SEER)数据库的研究:可切除的同侧肺转移非小细胞肺癌的预后因素和生存预测。
BMC Pulm Med. 2023 Oct 30;23(1):413. doi: 10.1186/s12890-023-02722-y.
8
The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.国际肺癌研究协会肺癌分期项目:即将出版的第九版肺癌 TNM 分类中 N 描述符修订建议。
J Thorac Oncol. 2024 May;19(5):766-785. doi: 10.1016/j.jtho.2023.10.012. Epub 2023 Oct 20.
9
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies.肺癌中免疫检查点抑制剂耐药的管理:治疗方法与新策略
J Clin Oncol. 2022 Feb 20;40(6):598-610. doi: 10.1200/JCO.21.01845. Epub 2022 Jan 5.
10
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.